Stock Comparison

ABT vs SNN

Abbott Laboratories and Smith & Nephew SNATS Inc side by side — valuation, profitability, growth and risk.

ABT

Abbott Laboratories

Healthcare

SNN

Smith & Nephew SNATS Inc

Healthcare

Valuation

Market Cap

$163.94B

$12.69B

P/E (TTM)

26.4

21.0

Forward P/E

17.2

13.6

Price/Sales

3.6

2.1

Price/Book

3.2

2.4

EV/EBITDA

16.1

10.1

Dividend Yield

2.62%

2.60%

Profitability

Net Margin

13.90%

10.10%

Operating Margin

13.50%

14.00%

Return on Equity

12.30%

11.80%

Return on Assets

5.59%

5.27%

Growth (YoY)

Revenue Growth

7.80%

7.40%

Earnings Growth

-19.70%

70.40%

Price & Risk

Beta

0.6

0.7

52-Week High

$135.34

$37.90

52-Week Low

$81.97

$28.60

Analyst Target

$116.54

$34.99

Compare ABT and SNN your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.